尿液分析市场 - 全球行业规模、份额、趋势、竞争、机会和预测，2018-2028 年。按产品、按测试类型、按应用、按最终用户、按地区和竞争细分

预计尿液分析市场在 2024-2028 年的预测期内将以令人印象深刻的复合年增长率增长。这可归因于糖尿病、肾病等慢性疾病患病率上升等因素。

慢性病患病率上升

糖尿病等慢性病患病率在全球范围内不断上升，引起了世界各地人口的巨大健康问题；例如，根据《国家糖尿病统计报告》，2020 年，大约有 3420 万人年龄在 18 岁以下。以上均患有糖尿病。此外，由于血压和血糖持续升高，大约三分之一的人口患有某种肾臟并发症。久坐的生活方式，包括食用不健康食品、饮酒、加工食品摄入量增加、缺乏运动等，正在导致世界各地糖尿病患病率不断上升。为了确定糖尿病患者的血糖水平或确认个体是否患有糖尿病，尿液分析是一个重要的步骤，并且在全球范围内经常进行。

尿路感染 (UTI) 的负担日益加重

尿液分析是识别尿路感染 (UTI) 的常用诊断程序。诊断程序通过检测和识别细胞、细菌、病毒、蛋白质、肌酐和浓度异常的物质来检查尿液。尿路感染最常见的原因是细菌通过尿道进入尿道并开始在膀胱中繁殖。最常见的尿液感染类型是膀胱感染（膀胱炎）。可用于诊断肾臟感染（多肾炎）。常见尿路感染的风险上升可能是由于既往尿路感染、怀孕、年龄（老年人尿路感染患病率增加）、更年期、卫生条件差等造成的，这反过来又支持了预计将推动的市场增长。预测期。

家用尿液检测套件的普及

家用尿液检测套件可用于在家检测是否存在尿路感染。尿路感染检测试剂盒通常用作妊娠检测试剂盒，在家几分钟内即可表明是否存在泌尿道感染。此外，这些检测试剂盒对于检测尿路感染的复发非常有帮助，从而采取进一步措施治愈它。此外，这些检测试剂盒还提供家庭尿液药物检测筛查，并且 100% 隐私。试剂盒旨在诊断大麻、可卡因、甲基苯丙胺等。该尿液药物检测试剂盒可用于家庭测试，适用于家庭药物测试、工作场所测试、学校、​​学院和大学药物测试、执法测试、严重药物滥用测试等

近期发展

2021 年 11 月，健康和营养指导初创公司 Vivoo 筹集了 600 万美元的投资，用于创建提供饮食和生活方式建议的家庭尿液检测。中低收入国家正在投资这些价格低廉但功能相似的分析仪。

可用的定制

利用给定的市场数据，TechSci Research 可根据公司的具体需求提供定制服务。该报告可以使用以下自定义选项：

公司信息

• 其他市场参与者（最多五个）的详细分析和概况分析。

目录

第 1 章：产品概述

• 市场定义
• 市场范围
  • 覆盖市场。
  • 考虑学习的年份
  • 主要市场细分

第 2 章：研究方法

• 研究目的
• 基线方法
• 主要行业合作伙伴
• 主要协会和二手资料来源
• 预测方法
• 数据三角测量和验证
• 假设和限制

第 3 章：执行摘要

• 市场概况
• 主要市场细分概述
• 主要市场参与者概述
• 重点地区/国家概况
• 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球尿液分析市场展望。

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按产品（消耗品和仪器）
  • 按测试类型（妊娠和生育力测试、生化尿液分析和沈淀物尿液分析）
  • 按应用（疾病筛查和怀孕与生育）
  • 按最终用户（诊断实验室、医院和诊所、家庭护理机构以及研究实验室和研究所）
  • 按公司划分 (2022)
  • 按地区
• 产品市场地图

第 6 章：亚太地区尿液分析市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 产品
  • 测试类型
  • 应用
  • 最终用户
  • 按国家/地区
• 亚太地区：国家分析
  • 中国 。
  • 印度 。
  • 韩国
  • 日本
  • 澳大利亚

第 7 章：欧洲尿液分析市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 产品
  • 测试类型
  • 应用
  • 最终用户
  • 按国家/地区
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 意大利
  • 西班牙

第 8 章：北美尿液分析市场展望。

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 产品
  • 测试类型
  • 应用
  • 最终用户
  • 按国家/地区
• 北美：国家分析
  • 美国尿液分析市场展望
    • 市场规模及预测
      • 按价值
    • 市场份额及预测
      • 产品
      • 测试类型
      • 应用
      • 最终用户
  • 墨西哥尿液分析市场展望
    • 市场规模及预测
      • 按价值
    • 市场份额及预测
      • 产品
      • 测试类型
      • 应用
      • 最终用户
  • 加拿大尿液分析市场展望
    • 市场规模及预测
      • 按价值
    • 市场份额及预测
      • 产品
      • 测试类型
      • 应用
      • 最终用户

第 9 章：南美尿液分析市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 类型
  • 产品类别
  • 组织
  • 最终用户
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲尿液分析市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 产品
  • 测试类型
  • 应用
  • 最终用户
  • 按国家/地区
• MEA：国家分析
  • 南非 尿液分析
  • 沙特阿拉伯 尿液分析
  • 阿联酋尿液分析
  • 科威特尿液分析

第 11 章：市场动态

• 司机
• 挑战

第 12 章：市场趋势与发展

• 最近的发展
• 併购
• 产品开发

第13章：竞争格局

• 商业概览
• 公司概况
• 产品与服务
• 财务（上市公司）
• 最近的发展
• SWOT分析
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthineers AG.
  • Abbott Laboratories
  • Cardinal Health Inc.
  • Danaher Corporation
  • Sysmex Corporation
  • Quidel Corporation
  • Becton, Dickinson & Company
  • Bio-Rad Laboratories Inc.
  • EKF Diagnostic s Holdings plc

第 14 章：战略建议

Urinalysis Market is expected to grow with an impressive CAGR in the forecast period of 2024-2028. This can be attributed to factors such as growing chronic disease prevalence, such as diabetes, kidney disease, etc.

Urinalysis is a test that examines the visual, chemical, and microscopic characteristics of urine. This test is utilized to detect and manage syndromes of diseases, such as kidney disease, urinary tract infections, and diabetes. Further, urinalysis being informative and a non-invasive diagnostic method for the identification of kidney disease propels the market demand for urinalysis and adds to the market growth.

Moreover, rising awareness of kidney and urinary tract infections among the population and increasing government initiatives, along with growing healthcare investments for the identification and management of the growing burden of kidney diseases, are some factors adding to the market growth and is anticipated to bolster the Global Urinalysis Market in the forecast period.

Rising Prevalence of Chronic Diseases

Rising chronic disease prevalence such as diabetes is increasing worldwide, causing a huge health concern among the population around the world; for instance, according to the National Diabetes Statistical Report, in 2020, approximately 34.2 million people aged 18 yrs. And above were affected with diabetes. Also, around one-third of the population was suffering some kind of kidney complication due to constant elevated blood pressure and blood sugar. The sedentary lifestyle, including consumption of unhealthy foods, alcohol consumption, increased processed food intake, lack of exercise, etc., is leading to the rising prevalence of diabetes around the world. To identify the glucose level in diabetic people or to confirm the diabetes occurrence in an individual, urinalysis is an important step and is frequently performed across the globe.

Growing Burden of Urinary Tract Infections (UTIs)

Urinalysis is a commonly utilized diagnostic procedure in the identification of a Urinary Tract infection (UTI). The diagnostic procedure examines the urine by detecting and identifying cells, bacteria, viruses, proteins, creatinine, and substances present in abnormal concentration. The most common cause of UTIs is when bacteria enter the urinary tract via the urethra and start flourishing in the bladder. The most common type of urine infection is bladder infection (cystitis). It can be used for the diagnosis of kidney infection (polynephritis). The rising risk of commonly observed UTI can be due to a previous UTI, pregnancy, age (older adults have increased UTI prevalence), menopause, poor hygiene, etc., and this is, in turn, supporting the market growth anticipated to boost in the forecast period.

The popularity of at-home Urine Testing Kits

At-home urine test kits are available for testing the presence of urinary tract infections at home. The UTI test kits commonly work as pregnancy test kits, which indicate the presence of a urinary infection in a few minutes at home. Also, these test kits are highly beneficial for testing the reoccurrence of a urinary tract infection, thereby taking further measures to get it cured. Furthermore, these test kits provide at-home screening for urine drug tests with 100% privacy. Kits are designed to diagnose marijuana, cocaine, methamphetamines, etc. This urine drug test kit is available for home-based tests suitable for home drug testing, workplace testing, school, college, and university drug testing, law enforcement testing, substantial drug abuse testing, etc.

Recent Development

In November 2021, Vivoo- a wellness and nutrition guidance startup, raised $6 million in investment for the creation of at-home urine testing that offers dietary and lifestyle advice. Middle-low-income countries are investing in these inexpensive but similarly functional analyzers.

Market Segmentation

Global Urinalysis Market is segmented based on the product, test type, application, end-user, and region. Based on the product, the market is segmented into consumables and instruments. Based on the test type, the market is segmented into pregnancy & fertility tests, biochemical urinalysis, and sediment urinalysis. Based on application, the market is fragmented into disease screening and pregnancy & fertility. Depending on the end user, the market is segmented into diagnostic laboratories, hospitals & clinics, home care settings, and research laboratories & institutes. Based on the region, the Market is further segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Market Players

F. Hoffmann-La Roche Ltd., Siemens Healthineers AG., Abbott Laboratories, Cardinal Health Inc., Danaher Corporation, Sysmex Corporation, Quidel Coorporation, Becton, Dickinson & Company, Bio-Rad Laboratories Inc., EKF Diagnostic s Holdings plc, etc.., are some of the major players operating in the global Urinalysis Market.

Report Scope

In this report, Global Urinalysis Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Urinalysis Market, By Product:

• Consumables
• Instruments

Urinalysis Market, By Test Type:

• Pregnancy & Fertility Tests
• Biochemical Urinalysis
• Sediment Urinalysis

Urinalysis Market, By Application:

• Disease Screening
• Pregnancy & Fertility

Urinalysis Market, By End User:

• Diagnostic Laboratories
• Hospitals & Clinics
• Home Care Settings
• Research Laboratories & Institutes

Urinalysis Market, By Region:

• North America
  • United States
  • Canada
  • Mexico

• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia

• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

• South America
  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Urinalysis Market.

Available Customizations

With the given Marketdata, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional Market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered.
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Urinalysis Market Outlook.

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Consumables & Instruments)
  • 5.2.2. By Test Type (Pregnancy & Fertility Tests, Biochemical Urinalysis, and Sediment Urinalysis)
  • 5.2.3. By Application (Disease Screening and Pregnancy & Fertility)
  • 5.2.4. By End user (Diagnostic Laboratories, Hospitals & Clinics, Home Care Settings, and Research Laboratories & Institutes)
  • 5.2.5. By Company (2022)
  • 5.2.6. By Region
• 5.3. Product Market Map

6. Asia-Pacific Urinalysis Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. Product
  • 6.2.2. Test Type
  • 6.2.3. Application
  • 6.2.4. End user
  • 6.2.5. By Country
• 6.3. Asia-Pacific: Country Analysis
  • 6.3.1. China Urinalysis Market Outlook.
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. Product
      • 6.3.1.2.2. Test Type
      • 6.3.1.2.3. Application
      • 6.3.1.2.4. End user
  • 6.3.2. India Urinalysis Market Outlook.
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. Product
      • 6.3.2.2.2. Test Type
      • 6.3.2.2.3. Application
      • 6.3.2.2.4. End user
  • 6.3.3. South Korea Urinalysis Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. Product
      • 6.3.3.2.2. Test Type
      • 6.3.3.2.3. Application
      • 6.3.3.2.4. End user
  • 6.3.4. Japan Urinalysis Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. Product
      • 6.3.4.2.2. Test Type
      • 6.3.4.2.3. Application
      • 6.3.4.2.4. End user
  • 6.3.5. Australia Urinalysis Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. Product
      • 6.3.5.2.2. Test Type
      • 6.3.5.2.3. Application
      • 6.3.5.2.4. End user

7. Europe Urinalysis Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. Product
  • 7.2.2. Test Type
  • 7.2.3. Application
  • 7.2.4. End user
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Urinalysis Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. Product
      • 7.3.1.2.2. Test Type
      • 7.3.1.2.3. Application
      • 7.3.1.2.4. End user
  • 7.3.2. Germany Urinalysis Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. Product
      • 7.3.2.2.2. Test Type
      • 7.3.2.2.3. Application
      • 7.3.2.2.4. End user
  • 7.3.3. United Kingdom Urinalysis Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. Product
      • 7.3.3.2.2. Test Type
      • 7.3.3.2.3. Application
      • 7.3.3.2.4. End user
  • 7.3.4. Italy Urinalysis Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. Product
      • 7.3.4.2.2. Test Type
      • 7.3.4.2.3. Application
      • 7.3.4.2.4. End user
  • 7.3.5. Spain Urinalysis Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. Product
      • 7.3.5.2.2. Test Type
      • 7.3.5.2.3. Application
      • 7.3.5.2.4. End user

8. North America Urinalysis Market Outlook.

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. Product
  • 8.2.2. Test Type
  • 8.2.3. Application
  • 8.2.4. End user
  • 8.2.5. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Urinalysis Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. Product
      • 8.3.1.2.2. Test Type
      • 8.3.1.2.3. Application
      • 8.3.1.2.4. End user
  • 8.3.2. Mexico Urinalysis Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. Product
      • 8.3.2.2.2. Test Type
      • 8.3.2.2.3. Application
      • 8.3.2.2.4. End user
  • 8.3.3. Canada Urinalysis Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. Product
      • 8.3.3.2.2. Test Type
      • 8.3.3.2.3. Application
      • 8.3.3.2.4. End user

9. South America Urinalysis Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. Type
  • 9.2.2. Product Type
  • 9.2.3. Tissue
  • 9.2.4. End user
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Urinalysis Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. Product
      • 9.3.1.2.2. Test Type
      • 9.3.1.2.3. Application
      • 9.3.1.2.4. End user
  • 9.3.2. Argentina Urinalysis Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. Product
      • 9.3.2.2.2. Test Type
      • 9.3.2.2.3. Application
      • 9.3.2.2.4. End user
  • 9.3.3. Colombia Urinalysis Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. Product
      • 9.3.3.2.2. Test Type
      • 9.3.3.2.3. Application
      • 9.3.3.2.4. End user

10. Middle East and Africa Urinalysis Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. Product
  • 10.2.2. Test Type
  • 10.2.3. Application
  • 10.2.4. End user
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Urinalysis Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. Product
      • 10.3.1.2.2. Test Type
      • 10.3.1.2.3. Application
      • 10.3.1.2.4. End user
  • 10.3.2. Saudi Arabia Urinalysis Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. Product
      • 10.3.2.2.2. Test Type
      • 10.3.2.2.3. Application
      • 10.3.2.2.4. End user
  • 10.3.3. UAE Urinalysis Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. Product
      • 10.3.3.2.2. Test Type
      • 10.3.3.2.3. Application
      • 10.3.3.2.4. End user
  • 10.3.4. Kuwait Urinalysis Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. Product
      • 10.3.4.2.2. Test Type
      • 10.3.4.2.3. Application
      • 10.3.4.2.4. End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Developments

13. Competitive Landscape

• 13.1. Business Overview
• 13.2. Company Snapshot
• 13.3. Products & Services
• 13.4. Financials (In case of listed companies)
• 13.5. Recent Developments
• 13.6. SWOT Analysis
  • 13.6.1. F. Hoffmann-La Roche Ltd.
  • 13.6.2. Siemens Healthineers AG.
  • 13.6.3. Abbott Laboratories
  • 13.6.4. Cardinal Health Inc.
  • 13.6.5. Danaher Corporation
  • 13.6.6. Sysmex Corporation
  • 13.6.7. Quidel Corporation
  • 13.6.8. Becton, Dickinson & Company
  • 13.6.9. Bio-Rad Laboratories Inc.
  • 13.6.10. EKF Diagnostic s Holdings plc

14. Strategic Recommendations